期限(时间)
医学
猫
重症监护医学
内科学
量子力学
物理
作者
Samantha Taylor,Margaret E. Gruen,Kate KuKanich,B. Duncan X. Lascelles,Beatriz Monteiro,Llibertat Real Sampietro,Sheilah A. Robertson,Paulo V. Steagall
标识
DOI:10.1177/1098612x241241951
摘要
Practical relevance: Non-steroidal anti-inflammatory drugs (NSAIDs) are widely used and are effective for the management of pain in cats. These Guidelines will support veterinarians in decision-making around prescribing NSAIDs in situations of chronic pain, to minimise adverse effects and optimise pain management. Information is provided on mechanism of action, indications for use, screening prior to prescription, use in the presence of comorbidities, monitoring of efficacy, and avoidance and management of adverse effects. Clinical challenges: The cat's unique metabolism should be considered when prescribing any medications, including NSAIDs. Chronic pain may be challenging to detect in this species and comorbidities, particularly chronic kidney disease, are common in senior cats. Management of chronic pain may be complicated by prescription of other drugs with the potential for interactions with NSAIDs. Evidence base: These Guidelines have been created by a panel of experts brought together by the International Society of Feline Medicine (ISFM) and American Association of Feline Practitioners (AAFP). Information is based on the available literature, expert opinion and the panel members' experience.
科研通智能强力驱动
Strongly Powered by AbleSci AI